The use of these services in oncology is likely here to stay.
McKesson | Strategic Alliance Partners
Latest from McKesson
Seven custom measures receive approval, raising the bar on oncology patient care.
Shereen Stutz and Mark Alwardt, of McKesson, said the rise in oral oncolytics during the COVID-19 pandemic allowed pharmacists to be more innovative and to become an even more integrated part of the oncology care team.
The pandemic taught the pharmacy to provide a deeper level of personalized care and communication than in the past.
The keys to this recovery will be innovation and collaboration, according to Craig Dolan, PharmD, MBA, of McKesson RxO.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare's New GLP-1 Bridge Program: What Pharmacists Need to Know Before Dispensing
2
Isatuximab Wins FDA Approval, Becoming Second Subcutaneous Anti-CD38 for Multiple Myeloma
3
Clots, Catheters, and Clinical Pearls: Pulmonary Embolism Updates for Practicing Pharmacists
4
Single-Shot Respiratory Vaccine Could Transform Pharmacist Counseling and Immunization Rates
5